Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
J Dairy Sci ; 100(8): 6090-6099, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28571988

ABSTRACT

Spore-forming bacteria, principally Bacillus species, are important contaminants of milk. Because of their high heat resistance, Bacillus species spores are capable of surviving the heat treatment process of milk and lead to spoilage of the final product. To determine the factors influencing the contamination of milk, spore-forming bacteria occurrence throughout the UHT milk production line during winter, spring, and summer was studied. The obtained results confirm that the total viable rate decreases rapidly throughout the production line of UHT milk showing the efficiency of thermal treatments used. However, the persistent high rate of spore-forming bacteria indicates their high heat resistance, especially in spring and summer. In addition, a significant variation of the quality of raw milk according to the location of the collecting centers was revealed. The molecular identification showed a high degree of diversity of heat-resistant Bacillus species, which are isolated from different milk samples. The distribution of Bacillus species in raw milk, stored milk, bactofuged milk, pasteurized milk, and UHT milk were 28, 10, 16, 13, and 33%, respectively. Six Bacillus spp. including Bacillus licheniformis (52.38%), Bacillus pumilus (9.52%), Bacillus sp. (4.76%), Bacillus sporothermodurans (4.76%), Terribacillus aidingensis (4.76%), and Paenibacillus sp. (4.76%) were identified in different milk samples.


Subject(s)
Bacillus/physiology , Food Microbiology , Hot Temperature , Milk/microbiology , Spores, Bacterial/growth & development , Animals , Seasons , Tunisia
2.
Arch Pediatr ; 26(2): 102-107, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30638765

ABSTRACT

BACKGROUND AND OBJECTIVES: Sanjad-Sakati syndrome (SSS; OMIM 241410) is a rare autosomal recessive disorder found almost exclusively in people of Arab origin. It is characterized by congenital hypoparathyroidism, severe prenatal and postnatal growth retardation, and distinct facial dysmorphism. The molecular pathology of this syndrome was shown to be due to a mutation in the tubulin-specific chaperone E (TBCE) gene in chromosomal area 1q42-q43. We aimed to detect and confirm the common mutation responsible for SSS in Tunisian patients and review the literature in order to create a set of clinical diagnostic criteria that might provide appropriate indications for molecular testing. METHODS: Three Tunisian patients with clinical feature of SSS were examined via direct Sanger sequencing of exon 3 of the TBCE gene. RESULTS: Mutation analysis of the TBCE gene revealed the common 12-bp (155-166del) deletion in three new patients, thus raising the number of reported SSS patients to 73. Reviewing the literature, we suggest a scoring system that assigns one point each for major criteria and one half point for minor criteria. INTERPRETATION AND CONCLUSIONS: SSS is an autosomal recessive disorder found in the Middle Eastern population with an estimated incidence of 1 per 40,000-100,000 live births in Saudi Arabia. Reviewing the literature on both its clinical and biochemical characteristics, we suggest for the first time, based on defined major and minor SSS criteria, a clinical scoring system for the diagnosis of SSS. On the one hand, an established scoring system will provide appropriate indications for molecular testing and, on the other hand, reviewed data on SSS will help delineate the phenotype and draw a distinction between differential diagnoses.


Subject(s)
Abnormalities, Multiple/diagnosis , Growth Disorders/diagnosis , Hypoparathyroidism/diagnosis , Intellectual Disability/diagnosis , Molecular Chaperones/genetics , Osteochondrodysplasias/diagnosis , Seizures/diagnosis , Abnormalities, Multiple/genetics , Consensus , Female , Genetic Markers , Growth Disorders/genetics , Humans , Hypoparathyroidism/genetics , Infant , Infant, Newborn , Intellectual Disability/genetics , Male , Osteochondrodysplasias/genetics , Seizures/genetics , Sequence Deletion , Tunisia
3.
Transfus Clin Biol ; 25(1): 14-18, 2018 Feb.
Article in French | MEDLINE | ID: mdl-29199112

ABSTRACT

AIM: Our objectives were to assess the management of patients with major thalassemia and identify the various complications and monitoring means. PATIENTS AND METHODS: A retrospective study was conducted on 26 ß-thalassemic patients in the department of paediatrics, Hédi Chaker hospital, Sfax, Tunisia during a period of 25 years (from 1 January 1990 to 31 December 2014). RESULTS: The mean age of the beginning of transfusion was 11.5 months. That was with phenotyped red blood cells but not leukodepleted blood. Twenty-three patients received chelation. Before 2001, all patients received deferoxamine, poor adherence to this treatment was observed in 66% of cases. It was replaced by deferiprone since 2006 and deferasirox since 2009. A combination of 2 or 3 chelators was indicated for four patients. A total splenectomy was performed in 10 cases patients; it was due to hypersplenism. The bone marrow transplant was performed for one patient at the age of 9 year but it was rejected. Many complications were detected: endocrine complications (19 cases), immune complications (9 cases), gallbladder stones (5 cases), cardiac complications (4 cases), osteoporosis (3 cases), infectious complications (3 cases) and thromboembolic complications (2 cases). We noted some side effects related to chelation therapy in twelve cases. Four patients were dead. CONCLUSION: Improving the medical care of homozygous ß-thalassemic children requires adherence to transfusion regimen and chelation therapy. Bone marrow transplantation remains the only possible curative therapy, which must be promoted in our country.


Subject(s)
beta-Thalassemia/therapy , Blood Grouping and Crossmatching/statistics & numerical data , Blood Transfusion/statistics & numerical data , Chelation Therapy/adverse effects , Chelation Therapy/statistics & numerical data , Child, Preschool , Combined Modality Therapy , Disease Management , Female , Hospital Departments , Hospitals, Urban/statistics & numerical data , Humans , Infant , Iron Chelating Agents/adverse effects , Iron Chelating Agents/therapeutic use , Leukocyte Reduction Procedures/statistics & numerical data , Male , Pediatrics , Retrospective Studies , Splenectomy/statistics & numerical data , Transfusion Reaction , Tunisia , beta-Thalassemia/drug therapy
5.
Arch Pediatr ; 21(3): 291-5, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24462295

ABSTRACT

Childhood multiple sclerosis is a rare demyelinating autoimmune disease with particular features. Onset of multiple sclerosis is extremely uncommon in early childhood, particularly before 6 years of age. We report the case of a 5-year-old girl admitted to the hospital for altered consciousness and rapid onset of right hemiparaplegia. Magnetic resonance imaging (MRI) of the brain showed multifocal white matter disease with T2 hyperintense oval lesions in subcortical, periventricular, and cerebellar hemispheres. Treatment with high dose intravenous methylprednisolone (30 mg/kg/day for 3 days) improved symptoms. Intravenous corticosteroid therapy was followed by 1mg/kg/day of oral prednisone. A second MRI, 40 days later, revealed new disseminated T2 hyperintense lesions in the frontal periventricular white matter, corpus callosum, left middle cerebellar peduncle, and dorsal spinal cord, leading to the diagnosis of multiple sclerosis. Azathioprine (2.5 mg/kg/day) was started and the steroid dose was tapered before being stopped after 3 months. After 2 years of follow-up, the patient has remained asymptomatic with a normal neurological exam and with no relapse or side effects of azathioprine. This work shows the particularities in clinical and radiological features of multiple sclerosis in a child aged less than 6 years.


Subject(s)
Multiple Sclerosis/diagnosis , Age Factors , Child, Preschool , Female , Humans , Magnetic Resonance Imaging
6.
Arch Pediatr ; 21(1): 66-9, 2014 Jan.
Article in French | MEDLINE | ID: mdl-24290188

ABSTRACT

Acute ethmoiditis is a rare infection of ethmoidal cells. The pathognomonic sign is an edema of the internal corner of the eye. Imaging may be necessary to verify the absence of orbital or endocranial complications. Thrombophlebitis of the cavernous sinus is a serious complication of this infectious process. We report the case of an 11-year-old boy who presented with ethmoiditis complicated with thrombophlebitis of the cavernous sinus, with right hemiplegia and left Bell palsy sequelae. Early diagnosis of this disorder and urgent therapy are essential. Treatment is based on the antibiotic therapy.


Subject(s)
Cavernous Sinus Thrombosis/etiology , Ethmoid Sinusitis/complications , Methicillin-Resistant Staphylococcus aureus , Staphylococcal Infections/complications , Acute Disease , Cavernous Sinus/pathology , Cavernous Sinus Thrombosis/diagnosis , Cavernous Sinus Thrombosis/drug therapy , Combined Modality Therapy , Drug Therapy, Combination , Early Diagnosis , Ethmoid Sinus/pathology , Ethmoid Sinusitis/diagnosis , Ethmoid Sinusitis/drug therapy , Facial Paralysis/diagnosis , Facial Paralysis/etiology , Hemiplegia/diagnosis , Hemiplegia/etiology , Humans , Magnetic Resonance Imaging , Physical Therapy Modalities , Rifampin/therapeutic use , Staphylococcal Infections/diagnosis , Staphylococcal Infections/drug therapy , Tomography, X-Ray Computed , Vancomycin/therapeutic use
7.
Arch Pediatr ; 18(9): 970-3, 2011 Sep.
Article in French | MEDLINE | ID: mdl-21820292

ABSTRACT

Aicardi syndrome is a rare neurodevelopmental disorder characterized by corpus callosum agenesis, chorioretinal lacunae and early-onset infantile spasms. We report a particular case of Aicardi syndrome characterized by the association of the classical triad of severe bilateral ptosis, pontocerebellar hypoplasia, and perisylvian polymicrogyria in a girl born to non-consanguineous parents, but whose mother suffered from idiopathic generalized epilepsy.


Subject(s)
Aicardi Syndrome/complications , Aicardi Syndrome/diagnosis , Blepharoptosis/congenital , Blepharoptosis/complications , Brain/pathology , Agenesis of Corpus Callosum/complications , Agenesis of Corpus Callosum/diagnosis , Agenesis of Corpus Callosum/genetics , Aicardi Syndrome/drug therapy , Aicardi Syndrome/genetics , Aicardi Syndrome/pathology , Anticonvulsants/therapeutic use , Cerebellum/pathology , Drug Therapy, Combination , Female , Glucocorticoids/therapeutic use , Humans , Infant , Malformations of Cortical Development/complications , Malformations of Cortical Development/diagnosis , Malformations of Cortical Development/genetics , Pons/pathology , Prognosis , Risk Factors , Spasms, Infantile/diagnosis , Vigabatrin/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL